Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 6
1966 1
1967 1
1969 1
1971 1
1972 3
1973 2
1974 6
1975 6
1976 6
1977 7
1978 14
1979 10
1980 13
1981 9
1982 12
1983 11
1984 20
1985 31
1986 19
1987 32
1988 39
1989 38
1990 44
1991 45
1992 39
1993 51
1994 72
1995 61
1996 66
1997 78
1998 81
1999 82
2000 88
2001 107
2002 107
2003 85
2004 114
2005 122
2006 114
2007 115
2008 98
2009 120
2010 113
2011 128
2012 150
2013 176
2014 185
2015 195
2016 191
2017 194
2018 205
2019 183
2020 246
2021 260
2022 184
2023 198
2024 72

Text availability

Article attribute

Article type

Publication date

Search Results

4,221 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Beta-thalassemia-X-linked thrombocytopenia syndrome"
Page 1
Hemolytic-Uremic Syndrome in Children.
Boyer O, Niaudet P. Boyer O, et al. Pediatr Clin North Am. 2022 Dec;69(6):1181-1197. doi: 10.1016/j.pcl.2022.07.006. Epub 2022 Oct 29. Pediatr Clin North Am. 2022. PMID: 36880929 Review.
Hemolytic uremic syndrome is characterized by a triad of microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney failure. ...Complement inhibitors, such as eculizumab, have considerably improved the prognosis....
Hemolytic uremic syndrome is characterized by a triad of microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney …
Complications of massive transfusion.
Sihler KC, Napolitano LM. Sihler KC, et al. Chest. 2010 Jan;137(1):209-20. doi: 10.1378/chest.09-0252. Chest. 2010. PMID: 20051407 Review.
Blood transfusion in trauma, surgery, and critical care has been identified as an independent predictor of multiple organ failure, systemic inflammatory response syndrome, increased infection, and increased mortality in multiple studies. ...
Blood transfusion in trauma, surgery, and critical care has been identified as an independent predictor of multiple organ failure, sy …
Etiology and Outcomes of Thrombotic Microangiopathies.
Bayer G, von Tokarski F, Thoreau B, Bauvois A, Barbet C, Cloarec S, Mérieau E, Lachot S, Garot D, Bernard L, Gyan E, Perrotin F, Pouplard C, Maillot F, Gatault P, Sautenet B, Rusch E, Buchler M, Vigneau C, Fakhouri F, Halimi JM. Bayer G, et al. Clin J Am Soc Nephrol. 2019 Apr 5;14(4):557-566. doi: 10.2215/CJN.11470918. Epub 2019 Mar 12. Clin J Am Soc Nephrol. 2019. PMID: 30862697 Free PMC article.
Secondary thrombotic microangiopathies are less characterized than primary thrombotic microangiopathies (thrombotic thrombocytopenic purpura and atypical hemolytic and uremic syndrome). The relative frequencies and outcomes of secondary and primary thrombotic microangiopat …
Secondary thrombotic microangiopathies are less characterized than primary thrombotic microangiopathies (thrombotic thrombocytopenic purpura …
TAFRO Syndrome.
Igawa T, Sato Y. Igawa T, et al. Hematol Oncol Clin North Am. 2018 Feb;32(1):107-118. doi: 10.1016/j.hoc.2017.09.009. Hematol Oncol Clin North Am. 2018. PMID: 29157612 Review.
TAFRO syndrome is a newly recognized variant of idiopathic multicentric Castleman disease (iMCD) that involves a constellation of syndromes: thrombocytopenia (T), anasarca (A), fever (F), reticulin fibrosis (R), and organomegaly (O). ...TAFRO syndrome
TAFRO syndrome is a newly recognized variant of idiopathic multicentric Castleman disease (iMCD) that involves a constellation of …
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.
Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S. Greinacher A, et al. N Engl J Med. 2021 Jun 3;384(22):2092-2101. doi: 10.1056/NEJMoa2104840. Epub 2021 Apr 9. N Engl J Med. 2021. PMID: 33835769 Free PMC article.
BACKGROUND: Several cases of unusual thrombotic events and thrombocytopenia have developed after vaccination with the recombinant adenoviral vector encoding the spike protein antigen of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (ChAdOx1 nCov-19, A …
BACKGROUND: Several cases of unusual thrombotic events and thrombocytopenia have developed after vaccination with the recombinant ade …
Epstein Syndrome.
Barrah S, Kheder R, Jebali H, Krid M, Smaoui W, Beji S, Hmida FB, Fatma LB, Rais L, Zouaghi MK. Barrah S, et al. Saudi J Kidney Dis Transpl. 2020 Jul-Aug;31(4):865-867. doi: 10.4103/1319-2442.292323. Saudi J Kidney Dis Transpl. 2020. PMID: 32801250
The prognosis of Epstein's syndrome depends on the severity of the hematological disorders and renal involvement that can lead to ESRD at an early age. Thrombocytopenia in Epstein syndrome is not an absolute contraindication for major surgical procedur …
The prognosis of Epstein's syndrome depends on the severity of the hematological disorders and renal involvement that can lead …
Eculizumab discontinuation in children and adults with atypical hemolytic-uremic syndrome: a prospective multicenter study.
Fakhouri F, Fila M, Hummel A, Ribes D, Sellier-Leclerc AL, Ville S, Pouteil-Noble C, Coindre JP, Le Quintrec M, Rondeau E, Boyer O, Provôt F, Djeddi D, Hanf W, Delmas Y, Louillet F, Lahoche A, Favre G, Châtelet V, Launay EA, Presne C, Zaloszyc A, Caillard S, Bally S, Raimbourg Q, Tricot L, Mousson C, Le Thuaut A, Loirat C, Frémeaux-Bacchi V. Fakhouri F, et al. Blood. 2021 May 6;137(18):2438-2449. doi: 10.1182/blood.2020009280. Blood. 2021. PMID: 33270832 Free article. Clinical Trial.
The optimal duration of eculizumab treatment in patients with atypical hemolytic uremic syndrome (aHUS) remains poorly defined. We conducted a prospective national multicenter open-label study to assess eculizumab discontinuation in children and adults with aHUS. ...
The optimal duration of eculizumab treatment in patients with atypical hemolytic uremic syndrome (aHUS) remains poorly defined. We co …
Thrombotic microangiopathies.
Halevy D, Radhakrishnan J, Markowitz G, Appel G. Halevy D, et al. Crit Care Clin. 2002 Apr;18(2):309-20, vi. doi: 10.1016/s0749-0704(01)00004-5. Crit Care Clin. 2002. PMID: 12053836 Review.
The thrombotic microangiopathies (TMA) are a group of diseases associated with microangiopathic hemolytic anemia, thrombocytopenia, and end-organ dysfunction. These seemingly disparate entities share in common a pathogenic mechanism involving endothelial injury and thrombu …
The thrombotic microangiopathies (TMA) are a group of diseases associated with microangiopathic hemolytic anemia, thrombocytopenia, a …
The utility of platelet activation biomarkers in thrombotic microangiopathies.
Al-Tamimi M, Qiao J, Gardiner EE. Al-Tamimi M, et al. Platelets. 2022 May 19;33(4):503-511. doi: 10.1080/09537104.2022.2026912. Epub 2022 Mar 15. Platelets. 2022. PMID: 35287530 Review.
Primary thrombotic microangiopathies (TMAs) are observed in thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS), while secondary TMAs have a wide range of etiologies. ...This review will summarize the current knowledge around platelet activation m …
Primary thrombotic microangiopathies (TMAs) are observed in thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome ( …
Congenital amegakaryocytic thrombocytopenia and thrombocytopenia with absent radii.
Geddis AE. Geddis AE. Hematol Oncol Clin North Am. 2009 Apr;23(2):321-31. doi: 10.1016/j.hoc.2009.01.012. Hematol Oncol Clin North Am. 2009. PMID: 19327586 Free PMC article. Review.
Thrombocytopenia is a relatively common clinical problem in hospitalized neonates, and it is critical to distinguish infants who have rare congenital thrombocytopenias from those who have acquired disorders. Two well-described inherited thrombocytopenia sy
Thrombocytopenia is a relatively common clinical problem in hospitalized neonates, and it is critical to distinguish infants who have
4,221 results